2019
Outcomes of upper tract urothelial cancer managed non-surgically.
Syed JS, Nguyen KA, Suarez-Sariemento A, Leung C, Casilla-Lennon M, Raman JD, Shuch B. Outcomes of upper tract urothelial cancer managed non-surgically. Canadian Journal Of Urology 2019, 26: 9699-9707. PMID: 31012833.Peer-Reviewed Original ResearchConceptsUpper tract urothelial cancerCharlson-Deyo scoreMedian overall survivalOverall survivalTumor gradeCox proportional hazards regression modelProportional hazards regression modelsNational Cancer DatabaseKaplan-Meier methodHazards regression modelsHigh-grade tumorsGovernment health insuranceDefinitive surgeryDefinitive therapyGreater comorbidityOlder patientsMedian agePatient demographicsWorse survivalUrothelial cancerGrade tumorsAlternative therapiesCancer DatabaseOS differenceRadiation therapy
2017
Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life
Casilla-Lennon MM, Choi SK, Deal AM, Bensen JT, Narang G, Filippou P, McCormick B, Pruthi R, Wallen E, Tan HJ, Woods M, Nielsen M, Smith A. Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life. Journal Of Urology 2017, 199: 1166-1173. PMID: 29155338, PMCID: PMC5947876, DOI: 10.1016/j.juro.2017.10.049.Peer-Reviewed Original ResearchConceptsQuality of lifeHealth Related QualityBladder cancerFinancial toxicityRelated qualitySpecific health related qualityCancer Survivorship CohortFisher's exact testStudent's t-testYounger patientsMedian ageMultivariable analysisSurvivorship cohortNoninvasive diseaseGeneral healthPatientsExact testMedical careCancerPoor healthMental healthCareTreatment costsSignificant predictorsFinancial burden